3J Co., Ltd.
Have updates for this profile? Please contribute data
= Subscriber Access Only
You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.
With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.
3J Co., Ltd. - overview
Established
2020
Location
Daegu, -, South Korea
Primary Industry
Medical Devices & Equipment
About
Based in South Korea, 3J Co. , Ltd. operates as an innovative health technology firm focused on women's vaginal health through advanced diagnostic services and personalized probiotic solutions. 3J Co.
, Ltd. specializes in women's health technology, particularly through its unique offerings in vaginal health diagnostics. Founded in 2020 in Daegu, South Korea, the company has engaged in three significant deals, with its most recent deal occurring on August 24, 2023. The CEO, Ji Park, leads the company towards its goals in a rapidly evolving health landscape.
cheKIT is a pioneering health technology company that focuses on women's vaginal health through innovative diagnostic services and personalized probiotic solutions. The company’s core offering is the vaginal microbiome test, which represents the first of its kind in South Korea, allowing users to assess their vaginal microbiome health. This test identifies underlying issues related to vaginal conditions, empowering women to manage their health proactively. Following the test, users receive tailored recommendations for probiotics to support their vaginal flora.
cheKIT aims to cater to women experiencing recurrent vaginal infections, providing them with practical solutions to improve their quality of life. The company's services are primarily targeted at the South Korean market, with aspirations to expand into other regions where women's health and wellness are increasingly prioritized. cheKIT generates revenue through direct-to-consumer transactions, focusing on the sale of its vaginal microbiome testing kits and associated probiotic products. Customers purchase the testing kit online, which includes a self-collection device for easy at-home sampling.
Upon completion of the test, users are provided with personalized recommendations for probiotic supplements. The pricing structure is designed to be accessible, with individual testing kits offered at competitive rates, alongside subscription options for ongoing probiotic supplies. This model fosters customer loyalty and positions cheKIT as a resource for women seeking to enhance their vaginal health. Their flagship offerings include the vaginal microbiome test and a curated selection of probiotics, designed specifically for women's health needs.
In August 2023, 3J Co. , Ltd. raised an undisclosed amount of Seed funding from new investor Korea Tech Incubator for Startup, being selected for Accelerator Investment-Driven Tech Incubator Program. The company will utilize this funding to further develop its vaginal microbiome test kits and expand its personalized women's health management services.
Future plans include launching new health management products aimed at improving women's wellness and expanding into international markets where women's health is a growing concern.
Current Investors
QUAD Ventures, Korea Tech Incubator for Startup
Primary Industry
Medical Devices & Equipment
Sub Industries
Diagnostic, Medical & Imaging Laboratories, Healthcare IT, Diagnostic Equipment, Medical Software
Website
www.chekit.kr
Verticals
HealthTech, Mobile Apps
Company Stage
Angel & Seed
Total Amount Raised
Subscriber access only

Time to go Pro
Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.